Quarterly report pursuant to Section 13 or 15(d)

Industry Segments (Schedule of Segment Reporting Information) (Details)

v3.22.0.1
Industry Segments (Schedule of Segment Reporting Information) (Details) - USD ($)
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Operating (loss) income $ (4,962,285) $ 19,187,157
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Operating (loss) income (4,962,285) 19,187,157
FC2 Segment [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Operating (loss) income 10,858,751 9,914,936
Pharmaceutical Segment [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Operating (loss) income (11,648,249) (5,858,837)
Corporate [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Operating (loss) income $ (4,172,787) 15,131,058
PREBOOST [Member] | FC2 Segment [Member] | Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Operating (loss) income   $ 415,000